Use of impella ventricular assist device in patients with severe coronary artery disease presenting with cardiac arrest

Venkatak Mukku, Qiangjun Cai, Syed Gilani, Kenichi Fujise, Alejandro Barbagelata

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Impella (Abiomed, Danvers, MA) is a percutaneously inserted ventricular assist device (VAD). It has been increasingly used in patients with severe heart failure, cardiogenic shock, and high-risk percutaneous intervention (PCI). However, the use and efficacy of Impella in patients with severe coronary artery disease (CAD) presenting with cardiac arrest has rarely been reported.The objective of this study is to report our center experience in using Impella VAD in CAD patients presenting with cardiac arrest. From December 2010 to March 2011, three patients with severe CAD presented to our center with cardiac arrest underwent PCI with Impella support. We reported three cases of severe CAD presenting with cardiac arrest successfully treated with PCI and Impella support. Our experience demonstrated that Impella VAD may play an adjunctive role in obtaining hemodynamic stability in these high-risk patients undergoing PCI. One of the patients was supported to left VAD implantation, and the other two had excellent neurological and functional recovery. Our reports suggest an important role of Impella in cardiac arrest population. Earlier Impella implantation after cardiac arrest might provide cardiac support and tissue perfusion until recovery or high-risk PCI.

Original languageEnglish (US)
Pages (from-to)163-166
Number of pages4
JournalInternational Journal of Angiology
Volume21
Issue number3
DOIs
StatePublished - Sep 2012

Fingerprint

Heart-Assist Devices
Heart Arrest
Coronary Artery Disease
Cardiogenic Shock
Heart Failure
Perfusion
Hemodynamics
Population

Keywords

  • cardiac
  • cardiopulmonary resuscitation
  • catheterization
  • coronary artery disease
  • intra-aortic balloon pump
  • percutaneous coronary intervention
  • ST segment elevation myocardial infarction
  • ventricular assist devices

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Use of impella ventricular assist device in patients with severe coronary artery disease presenting with cardiac arrest. / Mukku, Venkatak; Cai, Qiangjun; Gilani, Syed; Fujise, Kenichi; Barbagelata, Alejandro.

In: International Journal of Angiology, Vol. 21, No. 3, 09.2012, p. 163-166.

Research output: Contribution to journalArticle

@article{bacd176a608a48b381ed90429ec47933,
title = "Use of impella ventricular assist device in patients with severe coronary artery disease presenting with cardiac arrest",
abstract = "Impella (Abiomed, Danvers, MA) is a percutaneously inserted ventricular assist device (VAD). It has been increasingly used in patients with severe heart failure, cardiogenic shock, and high-risk percutaneous intervention (PCI). However, the use and efficacy of Impella in patients with severe coronary artery disease (CAD) presenting with cardiac arrest has rarely been reported.The objective of this study is to report our center experience in using Impella VAD in CAD patients presenting with cardiac arrest. From December 2010 to March 2011, three patients with severe CAD presented to our center with cardiac arrest underwent PCI with Impella support. We reported three cases of severe CAD presenting with cardiac arrest successfully treated with PCI and Impella support. Our experience demonstrated that Impella VAD may play an adjunctive role in obtaining hemodynamic stability in these high-risk patients undergoing PCI. One of the patients was supported to left VAD implantation, and the other two had excellent neurological and functional recovery. Our reports suggest an important role of Impella in cardiac arrest population. Earlier Impella implantation after cardiac arrest might provide cardiac support and tissue perfusion until recovery or high-risk PCI.",
keywords = "cardiac, cardiopulmonary resuscitation, catheterization, coronary artery disease, intra-aortic balloon pump, percutaneous coronary intervention, ST segment elevation myocardial infarction, ventricular assist devices",
author = "Venkatak Mukku and Qiangjun Cai and Syed Gilani and Kenichi Fujise and Alejandro Barbagelata",
year = "2012",
month = "9",
doi = "10.1055/s-0032-1324736",
language = "English (US)",
volume = "21",
pages = "163--166",
journal = "International Journal of Angiology",
issn = "1061-1711",
publisher = "Thieme Medical Publishers",
number = "3",

}

TY - JOUR

T1 - Use of impella ventricular assist device in patients with severe coronary artery disease presenting with cardiac arrest

AU - Mukku, Venkatak

AU - Cai, Qiangjun

AU - Gilani, Syed

AU - Fujise, Kenichi

AU - Barbagelata, Alejandro

PY - 2012/9

Y1 - 2012/9

N2 - Impella (Abiomed, Danvers, MA) is a percutaneously inserted ventricular assist device (VAD). It has been increasingly used in patients with severe heart failure, cardiogenic shock, and high-risk percutaneous intervention (PCI). However, the use and efficacy of Impella in patients with severe coronary artery disease (CAD) presenting with cardiac arrest has rarely been reported.The objective of this study is to report our center experience in using Impella VAD in CAD patients presenting with cardiac arrest. From December 2010 to March 2011, three patients with severe CAD presented to our center with cardiac arrest underwent PCI with Impella support. We reported three cases of severe CAD presenting with cardiac arrest successfully treated with PCI and Impella support. Our experience demonstrated that Impella VAD may play an adjunctive role in obtaining hemodynamic stability in these high-risk patients undergoing PCI. One of the patients was supported to left VAD implantation, and the other two had excellent neurological and functional recovery. Our reports suggest an important role of Impella in cardiac arrest population. Earlier Impella implantation after cardiac arrest might provide cardiac support and tissue perfusion until recovery or high-risk PCI.

AB - Impella (Abiomed, Danvers, MA) is a percutaneously inserted ventricular assist device (VAD). It has been increasingly used in patients with severe heart failure, cardiogenic shock, and high-risk percutaneous intervention (PCI). However, the use and efficacy of Impella in patients with severe coronary artery disease (CAD) presenting with cardiac arrest has rarely been reported.The objective of this study is to report our center experience in using Impella VAD in CAD patients presenting with cardiac arrest. From December 2010 to March 2011, three patients with severe CAD presented to our center with cardiac arrest underwent PCI with Impella support. We reported three cases of severe CAD presenting with cardiac arrest successfully treated with PCI and Impella support. Our experience demonstrated that Impella VAD may play an adjunctive role in obtaining hemodynamic stability in these high-risk patients undergoing PCI. One of the patients was supported to left VAD implantation, and the other two had excellent neurological and functional recovery. Our reports suggest an important role of Impella in cardiac arrest population. Earlier Impella implantation after cardiac arrest might provide cardiac support and tissue perfusion until recovery or high-risk PCI.

KW - cardiac

KW - cardiopulmonary resuscitation

KW - catheterization

KW - coronary artery disease

KW - intra-aortic balloon pump

KW - percutaneous coronary intervention

KW - ST segment elevation myocardial infarction

KW - ventricular assist devices

UR - http://www.scopus.com/inward/record.url?scp=84865978094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865978094&partnerID=8YFLogxK

U2 - 10.1055/s-0032-1324736

DO - 10.1055/s-0032-1324736

M3 - Article

VL - 21

SP - 163

EP - 166

JO - International Journal of Angiology

JF - International Journal of Angiology

SN - 1061-1711

IS - 3

ER -